Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema is a specially compounded medication designed to treat a range of inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. This unique formulation combines the anti-inflammatory properties of mesalamine with the beneficial effects of sodium butyrate, a short-chain fatty acid. Together, these ingredients work synergistically to reduce inflammation and alleviate symptoms associated with these conditions.

The medication is contained in a ready-to-use liquid formulation, housed in pre-filled enema bottles. This design ensures a convenient and hygienic method for rectal administration, making it an ideal solution for targeted treatment of constipation, bowel cleansing, or medication delivery. The measured dose of the solution allows for easy and controlled application, eliminating the need for additional preparation.

The retention enema form of this medication allows for a slow release of the active ingredients, providing a sustained therapeutic effect. This slow-release mechanism ensures that the medication remains in the body for a longer period, thereby maximizing its therapeutic benefits. This formulation is particularly effective in providing relief from symptoms such as abdominal pain, diarrhea, and rectal bleeding, which are commonly associated with ulcerative colitis and Crohn's disease.

Furthermore, Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema can also help reduce the risk of complications associated with these diseases, such as infection and malnutrition. By reducing inflammation and promoting healing in the bowel, this medication can help improve the overall quality of life for individuals suffering from these conditions.

At Bayview Pharmacy, we are dedicated to providing our patients with the highest quality compounded medications. If you have any questions about Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema or any other compounded medications, please do not hesitate to contact us. We are here to assist you in finding the most effective treatment for your condition.

Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema is a ready-to-use liquid formulation contained in pre-filled enema bottles. This formulation is designed for rectal administration, providing a convenient and hygienic method for targeted treatment of ulcerative colitis, proctitis, and proctosigmoiditis. It offers a measured dose of the solution for easy and controlled application without the need for additional preparation.

This formulation is contraindicated in patients with known hypersensitivity to mesalamine or any of its components. It is also advised to exercise caution when administering this formulation to patients with renal impairment, as the sodium butyrate component may increase the risk of renal toxicity. Regular monitoring for signs and symptoms of renal toxicity, such as decreased urine output, increased serum creatinine, and increased blood urea nitrogen, is recommended.

Patients should also be monitored for signs and symptoms of mesalamine-induced adverse reactions, such as nausea, vomiting, abdominal pain, and headache. Concomitant use of this formulation with other medications that may increase the risk of renal toxicity, such as nonsteroidal anti-inflammatory drugs, should be avoided.

It is important to consult with a healthcare provider for any questions or concerns regarding the use of this formulation. The healthcare provider will be able to provide the most accurate and personalized advice based on the patient's specific condition and medical history.

Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema is a compounded prescription medication specifically designed for the treatment of ulcerative colitis, a type of inflammatory bowel disease. This unique formulation combines the anti-inflammatory properties of mesalamine with the inflammation-reducing and absorption-enhancing effects of sodium butyrate. Together, these active ingredients work synergistically to alleviate symptoms such as abdominal pain, diarrhea, and rectal bleeding by reducing inflammation in the colon and rectum.

The medication is presented in a ready-to-use liquid formulation contained in pre-filled enema bottles. This design ensures a convenient, hygienic, and targeted treatment approach for patients. The pre-measured dose of the solution allows for easy and controlled application, eliminating the need for additional preparation.

To administer the Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema, the patient should lie on their left side and gently insert the enema into the rectum. The enema should be held in place for 15 minutes before removal. Following this, the patient should continue to lie on their left side for an additional 15 minutes before standing up. This process should be repeated once daily for a period of up to 8 weeks, or as directed by a healthcare professional.

It is crucial to note that this medication should not be used by individuals who have a known allergy to mesalamine or sodium butyrate, or those with a history of kidney disease. Additionally, if you are pregnant or breastfeeding, it is essential to consult with your healthcare provider before starting this medication to ensure its safety for both you and your baby.

If you have any questions or concerns about the Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema, or if you need further clarification on its administration or how it works, please do not hesitate to reach out to your healthcare provider or pharmacist. They are equipped with the necessary knowledge and expertise to guide you through your treatment journey.

Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema is a ready-to-use liquid formulation contained in pre-filled enema bottles. This formulation is designed for rectal administration, providing a convenient and hygienic method for targeted treatment of various conditions. It offers a measured dose of the solution for easy and controlled application without the need for additional preparation.

This formulation has been used off-label for the treatment of radiation proctitis, an inflammation of the rectum caused by radiation therapy. It has also been used to treat anal fissures, fistulas, and abscesses. Additionally, it has been used to treat pouchitis, an inflammation of the ileal pouch, which is a surgically created reservoir for waste in patients with ulcerative colitis. It has also been used to treat perianal Crohn's disease, a condition in which the skin around the anus is affected by Crohn's disease.

Mesalamine 4 Gm/Sodium Butyrate 100 Mm Retention Enema has also been used to treat other inflammatory conditions of the rectum and anus, such as proctitis, proctosigmoiditis, and diverticulitis. It has also been used to treat rectal cancer, as well as to reduce the risk of recurrence of rectal cancer.

This formulation is generally well tolerated, with few side effects. Common side effects include abdominal pain, nausea, and diarrhea. If you have any questions about the use of this formulation for any of the above conditions, please consult with a healthcare professional.